论文信息 - Low-dose subcutaneous tocilizumab to prevent disease progression in patients with moderate COVID-19 pneumonia and hyperinflammation - 字舞流文

Low-dose subcutaneous tocilizumab to prevent disease progression in patients with moderate COVID-19 pneumonia and hyperinflammation

M. Di Nisio | A. Abbate | Nicola Potere | E. Porreca | G. Parruti | Silvio di Carlo | E. Polilli | A. Agostinone | A. Costantini | A. Spacone | G. Rizzo | Matteo La Vella